Your browser doesn't support javascript.
loading
SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome.
Wu, Huixuan; Iqbal, Junaid; Li, Long; Jiang, Hongli; Chao, Chen; Zhang, Meibiao; Li, Ou; Zhou, Houde.
Affiliation
  • Wu H; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 41
  • Iqbal J; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 41
  • Li L; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 41
  • Jiang H; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 41
  • Chao C; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 41
  • Zhang M; Department of Endocrinology and Metabolism, The First People's Hospital of Huaihua, Huaihua, Hunan 418000, China.
  • Li O; Department of Metabolism and Endocrinology, San-Sui County Traditional Chinese Medicine Hospital, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou 556000, China.
  • Zhou H; Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 41
Chin Med J (Engl) ; 137(11): 1372-1374, 2024 Jun 05.
Article in En | MEDLINE | ID: mdl-38602155
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Sodium-Glucose Transporter 2 Inhibitors / Hyperglycemia Limits: Adult / Female / Humans / Male Language: En Journal: Chin Med J (Engl) Year: 2024 Document type: Article Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Sodium-Glucose Transporter 2 Inhibitors / Hyperglycemia Limits: Adult / Female / Humans / Male Language: En Journal: Chin Med J (Engl) Year: 2024 Document type: Article Country of publication: China